Safety Profile
MOTS-c Side Effects: Frequency & Severity
MOTS-c has limited human safety data from early-stage clinical trials. Preclinical toxicology shows a clean profile.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Common side effects
1Injection site reactions
Mild and transient.
Uncommon side effects
2Transient fatigue
Reported in early doses.
Headache
Mild; typically resolves.
Contraindications
- Pregnancy
- Active malignancy (investigational)
- Known hypersensitivity
Drug interactions
- Limited published data
- Theoretical interaction with other AMPK activators (metformin)
Special populations
Not FDA approved. Insufficient data for pregnancy, pediatric, or elderly use.
Overall safety summary
MOTS-c is under active Phase I/II investigation. Preclinical data shows excellent tolerability; human data is still being collected.
MOTS-c side effects: FAQ
Is MOTS-c safe to combine with metformin?
Both activate AMPK through different routes. Theoretical additive effects exist but clinical interaction data is lacking.